Swiss Re AG
F:SR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
F:SR9
|
CH |
|
T
|
Theratechnologies Inc
NASDAQ:THTX
|
CA |
|
H
|
Huntington Bancshares Inc
XMUN:HU3
|
US |
|
BML Inc
OTC:BMLKF
|
JP |
|
Aena SME SA
F:A441
|
ES |
|
SGL Carbon SE
F:SGL
|
DE |
|
B
|
Banpu Power PCL
SET:BPP
|
TH |
|
Nick Scali Ltd
F:NJN
|
AU |
|
S
|
Schroders PLC
F:PYXA
|
UK |
|
Barsele Minerals Corp
XTSX:BME
|
CA |
|
A
|
Abasca Resources Inc
XTSX:ABA
|
CA |
|
C
|
CNOOC Ltd
F:NC2B
|
CN |
|
AGNC Investment Corp
NASDAQ:AGNC
|
US |
|
Hannover Rueck SE
F:HNRB
|
DE |
Wall St Price Targets
SR9 Price Targets Summary
Swiss Re AG
According to Wall Street analysts, the average 1-year price target for SR9 is 145.07 EUR with a low forecast of 126.18 EUR and a high forecast of 184.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SR9's stock price target?
Price Target
145.07
EUR
According to Wall Street analysts, the average 1-year price target for SR9 is 145.07 EUR with a low forecast of 126.18 EUR and a high forecast of 184.11 EUR.
What is the Revenue forecast for Swiss Re AG?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Swiss Re AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 6%.
